Evidence map›Paper›PMID 38649558›Full record

ArticleBiochemical genetics2025

First Transcriptome Analysis of Hepatoblastoma in Brazil: Unraveling the Pivotal Role of Noncoding RNAs and Metabolic Pathways.

Talita Ferreira Marques Aguiar, Maria Prates Rivas, Edson Mario de Andrade Silva, Sara Ferreira Pires, Gustavo Dib Dangoni, Taiany Curdulino Macedo, Alexandre Defelicibus, Bruna Durães de Figueiredo Barros, Estela Novak, Lilian Maria Cristofani and 9 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Talita Ferreira Marques Aguiar *Department of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil.
Maria Prates Rivas *Department of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil.
Edson Mario de Andrade Silva *Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Minas Gerais, Brazil.
Sara Ferreira PiresDepartment of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil.
Gustavo Dib DangoniDepartment of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil.
Taiany Curdulino MacedoDepartment of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil.
Alexandre DefelicibusInternational Center for Research, A. C. Camargo Cancer Center, São Paulo, Brazil.
Bruna Durães de Figueiredo BarrosInternational Center for Research, A. C. Camargo Cancer Center, São Paulo, Brazil.
Estela NovakPediatric Cancer Institute (ITACI) at the Pediatric Department, São Paulo University Medical School, São Paulo, Brazil.
Lilian Maria CristofaniPediatric Cancer Institute (ITACI) at the Pediatric Department, São Paulo University Medical School, São Paulo, Brazil.
Vicente OdonePediatric Cancer Institute (ITACI) at the Pediatric Department, São Paulo University Medical School, São Paulo, Brazil.
Monica CyprianoDepartment of Pediatrics, Adolescent and Child With Cancer Support Group (GRAACC), Federal University of São Paulo, São Paulo, Brazil.
Silvia Regina Caminada de ToledoDepartment of Pediatrics, Adolescent and Child With Cancer Support Group (GRAACC), Federal University of São Paulo, São Paulo, Brazil.
Isabela Werneck da CunhaDepartment of Pathology, Rede D'OR-São Luiz, São Paulo, Brazil.
Cecilia Maria Lima da CostaDepartment of Pediatric Oncology, A. C. Camargo Cancer Center, São Paulo, Brazil.
Dirce Maria CarraroInternational Center for Research, A. C. Camargo Cancer Center, São Paulo, Brazil.
Israel TojalInternational Center for Research, A. C. Camargo Cancer Center, São Paulo, Brazil.
Tiago Antonio de Oliveira MendesDepartment of Biochemistry and Molecular Biology, Federal University of Viçosa, Minas Gerais, Brazil.
Ana Cristina Victorino KrepischiDepartment of Genetics and Evolutionary Biology, Institute of Biosciences, Human Genome and Stem-Cell Research Center, University of São Paulo, São Paulo, Brazil. ana.krepischi@ib.usp.br.
AC Camargo Hospital · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRD’Or Institute for Research and Education · BRInstitute of Human Genetics · PLUniversidade Federal de Viçosa · BRUniversity of Florida · US

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305806/2019-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.816566/2023-00Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.903185/2023-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/08028-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/04785-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/23462-8
6 · The paper itself

Abstract

Hepatoblastoma stands as the most prevalent liver cancer in the pediatric population. Characterized by a low mutational burden, chromosomal and epigenetic alterations are key drivers of its tumorigenesis. Transcriptome analysis is a powerful tool for unraveling the molecular intricacies of hepatoblastoma, shedding light on the effects of genetic and epigenetic changes on gene expression. In this study conducted in Brazilian patients, an in-depth whole transcriptome analysis was performed on 14 primary hepatoblastomas, compared to control liver tissues. The analysis unveiled 1,492 differentially expressed genes (1,031 upregulated and 461 downregulated), including 920 protein-coding genes (62%). Upregulated biological processes were linked to cell differentiation, signaling, morphogenesis, and development, involving known hepatoblastoma-associated genes (DLK1, MEG3, HDAC2, TET1, HMGA2, DKK1, DKK4), alongside with novel findings (GYNG4, CDH3, and TNFRSF19). Downregulated processes predominantly centered around oxidation and metabolism, affecting amines, nicotinamides, and lipids, featuring novel discoveries like the repression of SYT7, TTC36, THRSP, CCND1, GCK and CAMK2B. Two genes, which displayed a concordant pattern of DNA methylation alteration in their promoter regions and dysregulation in the transcriptome, were further validated by RT-qPCR: the upregulated TNFRSF19, a key gene in the embryonic development, and the repressed THRSP, connected to lipid metabolism. Furthermore, based on protein-protein interaction analysis, we identified genes holding central positions in the network, such as HDAC2, CCND1, GCK, and CAMK2B, among others, that emerged as prime candidates warranting functional validation in future studies. Notably, a significant dysregulation of non-coding RNAs (ncRNAs), predominantly upregulated transcripts, was observed, with 42% of the top 50 highly expressed genes being ncRNAs. An integrative miRNA-mRNA analysis revealed crucial biological processes associated with metabolism, oxidation reactions of lipids and carbohydrates, and methylation-dependent chromatin silencing. In particular, four upregulated miRNAs (miR-186, miR-214, miR-377, and miR-494) played a pivotal role in the network, potentially targeting multiple protein-coding transcripts, including CCND1 and CAMK2B. In summary, our transcriptome analysis highlighted disrupted embryonic development as well as metabolic pathways, particularly those involving lipids, emphasizing the emerging role of ncRNAs as epigenetic regulators in hepatoblastomas. These findings provide insights into the complexity of the hepatoblastoma transcriptome and identify potential targets for future therapeutic interventions.

Indexed as

HepatoblastomaLiver NeoplasmsMetabolic Networks and PathwaysRNA, UntranslatedTranscriptomeBrazilChildChild, PreschoolDNA MethylationFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansInfantMaleRNA, UntranslatedHepatoblastomaLipidMetabolismNoncoding RNARNA-seqTranscriptome

Identifiers

PMID38649558
OpenAlexW4395012944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.